서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 42 of 42

Issue DateTitle / Author(s) / CitationFileAltmetrics
2005-09
High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization
DOI
2006-04
Validation study of the Korean version of the M. D. Anderson symptom inventory
DOI
2007
Castleman disease presenting with jaundice: a case with the multicentric hyaline vascular variant
view filelink
2007-07
Castleman disease presenting with jaundice: a case with the multicentric hyaline vascular variant
link
2008-02
Venous thromboembolism in patients with pancreatic adenocarcinoma: lower incidence in Asian ethnicity
link
2008-03
Weight changes after adjuvant treatment in Korean women with early breast cancer
link
2009-03
Weight changes after adjuvant treatment in Korean women with early breast cancer

Han, Hye-Suk; Lee, Keun-Wook; Kim, Jee Hyun; Kim, Sung-Won; Kim, In-Ah; Oh, Do-Youn; Im, Seock-Ah; Bang, Soo-Mee; Lee, Jong Seok

Breast Cancer Research and Treatment, Vol.114 No.1, pp.147-153

DOI
2009-09
Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement
DOI
2009-11
Immunoglobulin D Multiple Myeloma: Clinical Presentation, Response to Therapy and Prognostic Factors in 75 Patients; An Analysis of the Korean Multiple Myeloma Working Party (KMMWP).
2009-11
Patients with Hematologic Malignancies May Be at Higher Risk of Hepatitis B Reactivation in Spite of Lamivudine Prophylaxis
2009-11
Incidence and Biologic Features of 5q Deletion and 5q-Syndrome in Myelodysplastic Syndrome in Korea; According to Reclassification of Myelodysplastic Syndrome by WHO 2008.
2009-11
Clinical Efficacy and Tolerability of Granulocyte Transfusions for the Treatment of Febrile Neutropenia in the Patients with Hematologic Malignancies
2010-01
Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine
DOI
2010-11
Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML.
2010-11
Allogeneic Stem Cell Transplantation (alloSCT) and Donor Lymphocyte Infusion (DLI) In Patients with Non-Hodgkin Lymphoma (NHL) Who Experienced Relapse or Progression After Autologous Stem Cell Transplantation (autoSCT): Retrospective Analysis From the Korean Society of Blood and Marrow Transplantation.
2010-11
Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21).
2010-11
Interim Analysis of Randomized Phase II Study of Recombinant Human Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy with Stem Cell Transplantation for Hematologic Malignancies
2010-11
Incidence of Venous Thromboembolism In Korea: From Health Insurance Review and Assessment Service Database

Jang, Moon; Bang, Soo-Mee; Oh, Doyeun

BLOOD; Vol.116 21; 1508-1508

2010-12
Cytogenetic features of 5q deletion and 5q-syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization
DOI
2010-12
Korean Patients with Superwarfarin Intoxication and Their Outcome
view fileDOI
2014-03
Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients
DOI
2014-06
Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer
DOI
2015-05
Concurrent gastric and pulmonary mucosa-associated lymphoid tissue lymphomas with pre-existing intrinsic chronic inflammation: A case report and a review of the literature
DOI
2016-03
Differences in characteristics between first and breakthrough neutropenic fever after chemotherapy in patients with hematologic disease
DOI
2017-06
Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies
DOI
2017-09
EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release
DOI
2017-12
Clinical Dissection of Infectious Event Following ATG Treatment for Aplastic Anemia and Hypoplastic Myelodysplastic Syndrome Reveals Urgent Need for Anti-Aspergillus Prophylaxis
2018-01
Incidence of venous thromboembolism in Korea from 2009 to 2013
DOI
2018-02
Early therapeutic drug monitoring of posaconazole oral suspension in patients with hematologic malignancies
DOI
2018-05
Efficacy and safety of a new 10% intravenous immunoglobulin product in patients with primary immune thrombocytopenia (ITP)

Hong, Junshik; Bang, Soo-Mee; Mun, Yeung-Chul; Yhim, Ho-Young; Lee, Jaehoon; Lim, Hyeong-Seok; Oh, Doyeun

Journal of Korean Medical Science, Vol.33 No.19, p. e142

DOI
2018-07
The genetic polymorphism UGT1A4*3 is associated with low posaconazole plasma concentrations in hematological malignancy patients receiving the oral suspension
DOI
2018-10
BGJ398, a pan-FGFR inhibitor, overcomes paclitaxel resistance in urothelial carcinoma with FGFR1 overexpression
DOI
2018-10
A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study
DOI
2019-04
Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
DOI
2019-04
Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
view fileDOI
2020-09
Drug use evaluation of opioid analgesics in pain management among patients with hematopoietic stem cell transplantation
DOI
2021-12
R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience
DOI
2022-01
Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: A prospective cohort study
DOI
2022-07
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia
DOI
2022-10
Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease

Byun, Ja Min; Min, Chang-Ki; Kim, Kihyun; Bang, Soo-Mee; Lee, Je-Jung; Kim, Jin Seok; Yoon, Sung-Soo; Koh, Youngil

Journal of Hematology & Oncology. 2022 Oct 23;15(1):150

view filelink
2023-06
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy
view fileDOI
2025-01
GC1126A, a novel ADAMTS13 mutein, evades autoantibodies in immune-mediated thrombotic thrombocytopenic purpura
DOI
1